![TOGA Podcast artwork](https://is5-ssl.mzstatic.com/image/thumb/Podcasts124/v4/cb/1c/aa/cb1caabd-3426-78c1-9e3f-91606c3249c2/mza_5100909129334403906.jpg/100x100bb.jpg)
Underutilisation of Radiotherapy in Lung Cancer Treatment
TOGA Podcast
English - March 27, 2024 03:50 - 24 minutes - 22.3 MBMedicine Health & Fitness lung cancer oncology toga Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Revolutionising Lung Cancer Healthcare with AI: Unlocking the Future
Radiation therapy can be a very effective treatment for lung cancers, with 77% of patients indicating for radiation therapy in their disease trajectory. Yet, only 40% of patients with lung cancer in NSW receive radiation therapy.
In this podcast, Professor Shalini Vinod, Assoc Professor Mei-Ling Yap, and Dr Clare Bajraszewski discuss why radiation therapy is underutilised in lung cancer, what this means for patients, and potential solutions to address this.
This episode's host are:
Professor Shalini Vinod is a Radiation Oncologist at Liverpool Hospital and a Conjoint Professor at the South Western Sydney Clinical School, UNSW Sydney. She is also on the Board of Directors at TOGA.Associate Professor Mei-Ling Yap is a senior staff specialist Radiation Oncologist at Liverpool and Macarthur Cancer Therapy Centres in Sydney.Dr Clare Bajraszewski is a Radiation Oncologist at Peter MacCallum Cancer Centre at the Bendigo campus.Want to read more about radiation therapy?
A Population-based Model of Local Control and Survival Benefit of Radiotherapy for Lung Cancer